Pub-2006

Articles

Title
CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disorders
Characterization of familial Waldenstrom's macroglobulinemia
Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)
Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia
Infectious complications associated with alemtuzumab use for lymphoproliferative disorders
Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia